NIH Pauses SBIR Awards: Biotech Startups Grapple with Research Funding Drought Amid Budget Crisis
The NIH has suspended its SBIR program awards due to budget woes,…
CRISPR Breakthrough: First Human Trial Successfully Cures Rare Genetic Disease with No Side Effects
In a medical first, a Boston biotech firm cures Leber congenital amaurosis…
CRISPR Breakthrough: First Human Cure for Rare Muscle-Wasting Genetic Disease Achieved in Boston Biotech Trial
Boston biotech Vertex announces complete remission of Duchenne muscular dystrophy in first…
